Systematic review and meta-analysis on interventions for radiation dermatitis prevention and management: an overview of the methods.
Guidelines
Meta-analysis
Methods
Oncodermatology
Radiation dermatitis
Systematic review
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
13 Apr 2023
13 Apr 2023
Historique:
received:
23
11
2022
accepted:
26
03
2023
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Over several decades, research on the prevention and management of acute radiation dermatitis (RD) has continued to emerge, yet there remains no "gold standard" treatment for RD care. Recent guidelines on RD prevention and management were published in 2022 by the Oncodermatology Study Group of the Multinational Association of Supportive Care in Cancer (MASCC). As part of this guideline process, a collaborative effort was undertaken by international RD experts to quantitatively compare commonly studied RD skin interventions through meta-analyses and discern superiority of interventional treatments over another intervention, standard-of-care, or placebo in RD prevention and management. This paper summarizes the materials and methodology used in a set of meta-analysis studies that supplement the 2022 MASCC Clinical Practice Guidelines on RD Prevention and Management.
Identifiants
pubmed: 37052753
doi: 10.1007/s00520-023-07707-5
pii: 10.1007/s00520-023-07707-5
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
261Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Singh M, Alavi A, Wong R, Akita S (2016) Radiodermatitis: a review of our current understanding. Am J Clin Dermatol 17(3):277–292. https://doi.org/10.1007/s40257-016-0186-4
doi: 10.1007/s40257-016-0186-4
pubmed: 27021652
McQuestion M, Cashell A (2020) A qualitative descriptive study of patients’ experiences of a radiation skin reaction associated with treatment for a head and neck cancer. Can Oncol Nurs J 30(4):287–292
doi: 10.5737/23688076304287292
pubmed: 33165369
pmcid: 7597777
Chen M-F, Chen W-C, Lai C-H, Hung C-H, Liu K-C, Cheng Y-H (2010) Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer 10:508. https://doi.org/10.1186/1471-2407-10-508
doi: 10.1186/1471-2407-10-508
pubmed: 20860847
pmcid: 2955039
Wong RKS et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21(10):2933–2948. https://doi.org/10.1007/s00520-013-1896-2
doi: 10.1007/s00520-013-1896-2
Gosselin T et al (2020) ONS Guidelines™ for cancer treatment-related radiodermatitis. Oncol Nurs Forum 47(6):654–670. https://doi.org/10.1188/20.ONF.654-670
doi: 10.1188/20.ONF.654-670
pubmed: 33063779
Multinational Association of Supportive Care in Cancer (2018) “MASCC guidelines policy: recommendations for MASCC guideline construction and the endorsement of externally generated guidelines”
Behroozian T, Goldshtein D, Ryan Wolf J et al (2023) MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis: part 1) systematic review. eClinicalMedicine 101886. https://doi.org/10.1016/j.eclinm.2023.101886
Behroozian T, Bonomo P, Patel P et al (2023) Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations. Lancet Oncol 24(4):e172–e185. https://doi.org/10.1016/S1470-2045(23)00067-0
Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749–754. https://doi.org/10.1016/0895-4356(96)00019-4
doi: 10.1016/0895-4356(96)00019-4
pubmed: 8691224
“What is GRADE? | BMJ Best Practice.” https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ (accessed Jan. 28, 2022).
Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898
doi: 10.1136/bmj.l4898
pubmed: 31462531